Javascript must be enabled to continue!
OmniAge: a compendium of aging omic biomarkers links mitotic clocks to clonal hematopoiesis and causality
View through CrossRef
Abstract
Interest in aging ‘omic’ biomarkers has grown due to their ability to quantify biological age. Most of these biomarkers have been derived in blood and fall into many diverse categories, yet relatively little is known about their correlative patterns, especially between biomarkers from different categories. Here we present the
OmniAge
R and Python package, a collection of 413 aging omic biomarkers representing 12 different categories, including traditional epigenetic clocks, epigenetic mitotic clocks, DNA methylation-based proxies for clonal hematopoiesis and inflammaging, causal clocks, cell-type specific epigenetic clocks and single-cell transcriptomic clocks. By studying their inter-class correlations across large blood datasets, we reveal associations of mitotic age with clonal hematopoiesis subtypes and causal clocks, which are predictive of cancer risk. Using proxies of serum protein levels, we further dissect associations with mitotic clocks, clonal hematopoiesis and causal clocks into distinct biological processes mapping to key aging pathways. Applying
OmniAge
to multi-modal data of sorted immune cell-types reveals that age-acceleration derived from transcriptomic and epigenetic clocks correlate, but that this is driven by underlying cell-type heterogeneity. In summary, the
OmniAge
package is an exploratory tool for evaluating large numbers of aging omic biomarkers, and to aid discovery and generate new hypotheses.
Title: OmniAge: a compendium of aging omic biomarkers links mitotic clocks to clonal hematopoiesis and causality
Description:
Abstract
Interest in aging ‘omic’ biomarkers has grown due to their ability to quantify biological age.
Most of these biomarkers have been derived in blood and fall into many diverse categories, yet relatively little is known about their correlative patterns, especially between biomarkers from different categories.
Here we present the
OmniAge
R and Python package, a collection of 413 aging omic biomarkers representing 12 different categories, including traditional epigenetic clocks, epigenetic mitotic clocks, DNA methylation-based proxies for clonal hematopoiesis and inflammaging, causal clocks, cell-type specific epigenetic clocks and single-cell transcriptomic clocks.
By studying their inter-class correlations across large blood datasets, we reveal associations of mitotic age with clonal hematopoiesis subtypes and causal clocks, which are predictive of cancer risk.
Using proxies of serum protein levels, we further dissect associations with mitotic clocks, clonal hematopoiesis and causal clocks into distinct biological processes mapping to key aging pathways.
Applying
OmniAge
to multi-modal data of sorted immune cell-types reveals that age-acceleration derived from transcriptomic and epigenetic clocks correlate, but that this is driven by underlying cell-type heterogeneity.
In summary, the
OmniAge
package is an exploratory tool for evaluating large numbers of aging omic biomarkers, and to aid discovery and generate new hypotheses.
Related Results
Abstract LB497: Portraits of clonal landscape and mutational signature in primary tumors and matched lung metastatic model of osteosarcoma
Abstract LB497: Portraits of clonal landscape and mutational signature in primary tumors and matched lung metastatic model of osteosarcoma
Abstract
Objective:
The development of lung metastasis following primary tumor diagnosis, resection and chemotherapy rema...
A unique molecular identifier-based and clonal hematopoiesis-aware approach for accurate mutation calling in cell-free DNA assays.
A unique molecular identifier-based and clonal hematopoiesis-aware approach for accurate mutation calling in cell-free DNA assays.
e22515 Background: Given peripheral blood cells (PBCs) matched cell-free DNA (cfDNA), accurate mutation calling in next generation sequencing (NGS)-based assays relies on discrimi...
Successful Aging
Successful Aging
The emerging concept of successful aging is based on evidence that in healthy individual when they get aged, there are considerable variations in physiological functions alteratio...
Successful Aging
Successful Aging
The emerging concept of successful aging is based on evidence that in healthy individual when they get aged, there are considerable variations in physiological functions alterati...
Clonal Hematopoiesis in Cancer
Clonal Hematopoiesis in Cancer
Overview
Clonal hematopoiesis represents a precursor syndrome to development of hematologic malignancy. The discovery of clonal hematopoiesis resulted from improvement in...
Marker selection strategies for circulating tumor DNA guided by phylogenetic inference
Marker selection strategies for circulating tumor DNA guided by phylogenetic inference
Abstract
Motivation
Blood-based profiling of tumor DNA (“liquid biopsy”) has offered great prospects for non-invasive early can...
“Epigenetic clocks”: Theory and applications in human biology
“Epigenetic clocks”: Theory and applications in human biology
AbstractAll humans age, but how we age—and how fast—differs considerably from person to person. This deviation between apparent age and chronological age is often referred to as “b...
Epigenetics insights from perceived facial aging
Epigenetics insights from perceived facial aging
AbstractFacial aging is the most visible manifestation of aging. People desire to look younger than others of the same chronological age. Hence, perceived age is often used as a vi...

